{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:09:44Z","timestamp":1792642184468,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["ZY 2021-2023-0103"],"award-info":[{"award-number":["ZY 2021-2023-0103"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["ZD2021CY001"],"award-info":[{"award-number":["ZD2021CY001"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22071058"],"award-info":[{"award-number":["22071058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82141203"],"award-info":[{"award-number":["82141203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijbiomac.2023.128623","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T02:47:52Z","timestamp":1701917272000},"page":"128623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"P2","title":["Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity"],"prefix":"10.1016","volume":"257","author":[{"given":"Ruyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danmei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128623_bb0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"The Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128623_bb0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41591-023-02219-5","article-title":"Real-world COVID-19 vaccine effectiveness against the omicron BA.2 variant in a SARS-CoV-2 infection-naive population","volume":"29","author":"Lau","year":"2023","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128623_bb0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.128623_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(22)00192-8","article-title":"The future of Paxlovid for COVID-19","volume":"10","author":"Burki","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128623_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jmv.26256","article-title":"Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"93","author":"Huang","year":"2021","journal-title":"J. Med. Virol."},{"issue":"01","key":"10.1016\/j.ijbiomac.2023.128623_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1142\/S0192415X07004709","article-title":"Antiviral effects of Salvia miltiorrhiza (Danshen) against enterovirus 71","volume":"35","author":"Wu","year":"2007","journal-title":"Am. J. Chin. Med."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.128623_bb0035","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/jcp.24552","article-title":"Tanshinone II a inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK\/Nampt pathway","volume":"229","author":"Zhang","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.128623_bb0040","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/cells11081311","article-title":"Salvia miltiorrhiza Bunge as a potential natural compound against COVID-19","volume":"11","author":"Petitjean","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128623_bb0045","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/jmv.26874","article-title":"Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.128623_bb0050","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.1080\/07391102.2021.1918256","article-title":"In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins","volume":"40","author":"Elmaaty","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"47","key":"10.1016\/j.ijbiomac.2023.128623_bb0055","doi-asserted-by":"crossref","first-page":"29267","DOI":"10.1039\/D1RA05268C","article-title":"Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights","volume":"11","author":"Elebeedy","year":"2021","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128623_bb0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-020-00343-z","article-title":"A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.128623_bb0065","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1016\/j.bmc.2012.07.038","article-title":"Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases","volume":"20","author":"Park","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128623_bb0070","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41401-021-00714-4","article-title":"Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.128623_bb0075","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1016\/j.bmc.2012.07.038","article-title":"Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases","volume":"20","author":"Park","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128623_bb0080","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijbiomac.2021.04.129","article-title":"Identification of vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CL(pro)","volume":"183","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.128623_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144865","article-title":"Critical assessment of the important residues involved in the dimerization and catalysis of MERS coronavirus Main protease","volume":"10","author":"Ho","year":"2015","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.128623_bb0090","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1128\/JVI.79.11.7095-7103.2005","article-title":"Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.128623_bb0095","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"6498","key":"10.1016\/j.ijbiomac.2023.128623_bb0100","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2023.128623_bb0105","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijbiomac.2022.12.057","article-title":"Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein\/ACE2 interplay","volume":"226","author":"Xiang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.128623_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106264","article-title":"Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses","volume":"130","author":"Wang","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.128623_bb0115","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1021\/acs.jmedchem.1c00509","article-title":"Expedited approach toward the rational Design of Noncovalent SARS-CoV-2 Main protease inhibitors","volume":"65","author":"Kitamura","year":"2022","journal-title":"J. Med. Chem."},{"issue":"49","key":"10.1016\/j.ijbiomac.2023.128623_bb0120","doi-asserted-by":"crossref","first-page":"20697","DOI":"10.1021\/jacs.1c08060","article-title":"Discovery of Di- and Trihaloacetamides as covalent SARS-CoV-2 Main protease inhibitors with high target specificity","volume":"143","author":"Ma","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"6489","key":"10.1016\/j.ijbiomac.2023.128623_bb0125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128623_bb0130","first-page":"33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128623_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.720018","article-title":"Ugonin J acts as a SARS-CoV-2 3C-like protease inhibitor and exhibits anti-inflammatory properties","volume":"12","author":"Chiou","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.128623_bb0140","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1021\/acsptsci.0c00216","article-title":"Identification of inhibitors of SARS-CoV-2 3CL-pro enzymatic activity using a small molecule in vitro repurposing screen","volume":"4","author":"Kuzikov","year":"2021","journal-title":"ACS Pharmacology & Translational Science"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128623_bb0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128623_bb0150","first-page":"184","article-title":"Structural characterization of metabolites of salvianolic acid B from Salvia miltiorrhiza in normal and antibiotic-treated rats by liquid chromatography\u2013mass spectrometry","volume":"858","author":"Xu","year":"2007","journal-title":"J. Chromatogr. B"},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.128623_bb0155","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41589-022-01088-2","article-title":"A new dawn beyond lysine ubiquitination","volume":"18","author":"Squair","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.128623_bb0160","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/acsinfecdis.0c00815","article-title":"Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19","volume":"7","author":"Steuten","year":"2021","journal-title":"ACS Infectious Diseases"},{"issue":"7909","key":"10.1016\/j.ijbiomac.2023.128623_bb0165","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","article-title":"A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic","volume":"605","author":"Shapira","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.128623_bb0170","first-page":"146","article-title":"Pharmacokinetics and bioavailability study of danshensu in rat","volume":"33","author":"Pan","year":"2008","journal-title":"China Journal of Chinese Materia Medica"},{"key":"10.1016\/j.ijbiomac.2023.128623_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00554","article-title":"Preclinical absorption, distribution, metabolism, and excretion of sodium Danshensu, one of the Main water-soluble ingredients in Salvia miltiorrhiza, in rats","volume":"10","author":"Meng","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.ijbiomac.2023.128623_bb0180","doi-asserted-by":"crossref","first-page":"10091","DOI":"10.1021\/acs.jmedchem.9b01596","article-title":"Facts, patterns, and principles in drug discovery: appraising the rule of 5 with measured physicochemical data","volume":"63","author":"Tinworth","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.128623_bb0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/15376510902810672","article-title":"Acute and subchronic toxicity of danshensu in mice and rats","volume":"19","author":"Gao","year":"2009","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.ijbiomac.2023.128623_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172710","article-title":"Therapeutic potentials and mechanisms of the Chinese traditional medicine Danshensu","volume":"864","author":"Zhang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.128623_bb0195","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3389\/fphar.2018.01445","article-title":"Danshensu for myocardial ischemic injury: preclinical evidence and novel methodology of quality assessment tool","volume":"9","author":"Bao","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"7811","key":"10.1016\/j.ijbiomac.2023.128623_bb0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.128623_bb0205","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","article-title":"Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography","volume":"11","author":"Kneller","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.128623_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2023.128623_bb0215","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117142119","article-title":"Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2","volume":"119","author":"Zhao","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.128623_bb0220","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","article-title":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra \u03b1-helical domain","volume":"21","author":"Anand","year":"2002","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.128623_bb0225","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acscentsci.3c00538","article-title":"Naturally occurring mutations of SARS-CoV-2 Main protease confer drug resistance to Nirmatrelvir","volume":"9","author":"Hu","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ijbiomac.2023.128623_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.crchbi.2022.100025","article-title":"Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease","volume":"2","author":"Yang","year":"2022","journal-title":"Current Research in Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2023.128623_bb0235","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijbiomac.2021.07.167","article-title":"Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: inhibition potentials, covalent binding sites and inhibitory mechanisms","volume":"187","author":"Xiong","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"6575","key":"10.1016\/j.ijbiomac.2023.128623_bb0240","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"issue":"6497","key":"10.1016\/j.ijbiomac.2023.128623_bb0245","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023055228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023055228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:13:04Z","timestamp":1777482784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023055228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":49,"alternative-id":["S0141813023055228"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128623","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128623"}}